Background SARS-CoV-2 has drastically affected healthcare globally and causes COVID-
19, a disease that is associated with substantial morbidity and mortality. We aim to describe …

Background: We sought to determine the incidence of community-onset and hospital-
acquired coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19) and …

Purpose To investigate antimicrobial use and primary and nosocomial infections in
hospitalized COVID-19 patients to provide data for guidance of antimicrobial therapy …

Purpose The goal of our review was to gather information on the most important community-
acquired and hospital-acquired co-infections among coronavirus disease 2019 (COVID-19) …

Objectives To describe the burden, epidemiology and outcomes of co-infections and
superinfections occurring in hospitalized patients with coronavirus disease 2019 (COVID …

Background Recent research highlights the contribution of co-infections to elevated disease
severity and mortality among COVID-19 patients. Given China's decision to ease epidemic …

The clinical severity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
infection may rise because of acquiring a co-infection during the hospital stay of the patients …

Introduction. During previous viral pandemics, reported co-infection rates and implicated
pathogens have varied. In the 1918 influenza pandemic, a large proportion of severe illness …

Background We performed a nationwide population-based retrospective study to describe
the epidemiology of bacterial co-infections in coronavirus disease 2019 (COVID-19) …

Introduction The recovery of other pathogens in patients with SARS-CoV-2 infection has
been reported, either at the time of a SARS-CoV-2 infection diagnosis (co-infection) or …